Buys
Open market- Shares
- Avg price
- Total value
Tilak Mandadi - EVP, Chief Exp & Tech Officer at CVS HEALTH Corp
Issuer-level insider activity
- Role
- EVP, Chief Exp & Tech Officer
- Issuer ticker
- CVS on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Tilak Mandadi in CVS HEALTH Corp
Sells
Open market- Shares
- -69,551
- Avg price
- $89.58
- Total value
- -$6,230,379
Net
Past year- Shares
- -69,551
- Share %
- -100%
- Total value
- -$6,230,379
Reported holdings for Tilak Mandadi in CVS HEALTH Corp
Form 4 holding
EVP, Chief Exp & Tech Officer
CVS HEALTH Corp
- Security class
- Stock Option
- Shares / value
- 143,712
- Estimated value
- $5,937,101
- Report date
- 31 Mar 2026
- Price
- $67.98
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 67,920
Form 4 holding
EVP, Chief Exp & Tech Officer
CVS HEALTH Corp
- Security class
- Common Stock
- Shares / value
- 10,133
- Estimated value
- $907,714
- Report date
- 08 May 2026
- Price
- $89.58
- Ownership
- Direct
Transaction history for Tilak Mandadi in CVS HEALTH Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.